Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction
•To study risk factors for hemorrhagic transformation (HT) in non-thrombolysis patients.•Hyperlipemia, atrial fibrillation, plateletcount, INR > 1.7 are correlated with HT.•Hyperlipemia is a protective factor for HT.•Atrial fibrillation, plateletcount, INR > 1.7 are the risk factors for HT. He...
Gespeichert in:
| Veröffentlicht in: | Clinical neurology and neurosurgery 2019-06, Vol.181, p.68-72 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 72 |
|---|---|
| container_issue | |
| container_start_page | 68 |
| container_title | Clinical neurology and neurosurgery |
| container_volume | 181 |
| creator | Jiao, Yonggang Li, Guocai Xing, Yilan Nie, Da'ao Liu, Xintong |
| description | •To study risk factors for hemorrhagic transformation (HT) in non-thrombolysis patients.•Hyperlipemia, atrial fibrillation, plateletcount, INR > 1.7 are correlated with HT.•Hyperlipemia is a protective factor for HT.•Atrial fibrillation, plateletcount, INR > 1.7 are the risk factors for HT.
Hemorrhagic transformation (HT) is a serious complication of acute cerebral infarction. The aim of study is to investigate the influencing factors of HT in non-thrombolysis patients with acute cerebral infarction, and to explore its clinical significance.
From June 2016 to March 2017, a total of 346 non-thrombolysis patients with acute cerebral infarction hospitalized in the Department of Neurology of Guangdong Second Provincial General Hospital, were chosen and randomly devided into the non-HT group (control) and HT group. A record of 17 indices including the patients’age, gender, hypertension, diabetes, dyslipidemia, hyperhomocystinemia, atrial fibrillation, drinking or smoking, anticoagulation, antithrombosis, international normalized ratio (INR) and platelet count were measured. Then regression analysis was made to find the independent factors for HT.
It was found that 38 of non-thrombolysis patients with acute cerebral infarction involved in this study were with HT. The indices including dyslipidemia, drinking, atrial fibrillation, antiplatelet aggregation, anticoagulation, INR > 1.7, cholesterin, triglyceride and platelet count showed statistical differences between the HT group and the non-HT group (P 1.7 (OR=10.889, 95% CI 4.760–24.910, P = 0.000) and HT.
There is independent correlation between dyslipidemia, atrial fibrillation, platelet count, INR > 1.7 and HT. Dyslipidemia is the protective factor for HT, and atrial fibrillation, platelet count, INR > 1.7 are the risk factors for HT. |
| doi_str_mv | 10.1016/j.clineuro.2019.04.018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2213924525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303846719301210</els_id><sourcerecordid>2213924525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-c32b37fe08509e3ac495f042e734763d2a87324d24b6f07f7f8f44632c9c9b703</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EokvhK1SWuHBJmNiOHd9AFX8qVeICZ8txxrteJfZiJ6B-e7zalgMXLp6Df-_N6D1CbjpoO-jk-2Pr5hBxy6ll0OkWRAvd8IzsukGxRmo5PCc74MCbQUh1RV6VcgQAzuXwklzx6tGDhB3Z30U_bxhdiHvqrVtTLjR5esAl5Xyw--Domm0sPuXFriFFGiKNKTbrIadlTPNDCYWe6hfGtdDfYT1QhxnHbOeKepvdWfWavPB2LvjmcV6TH58_fb_92tx_-3J3-_G-cVzLtb5s5MojDD1o5NYJ3XsQDBUXSvKJ2UFxJiYmRulBeeUHL4TkzGmnRwX8mry7-J5y-rlhWc0SisN5thHTVgxjHddM9Kyv6Nt_0GPacqzXnalBM1VDqpS8UC6nUjJ6c8phsfnBdGDOVZijearCnKswIEytogpvHu23ccHpr-wp-wp8uABY8_gVMJviaogOp5DRrWZK4X87_gDuKp77</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2218927015</pqid></control><display><type>article</type><title>Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>ProQuest Central UK/Ireland</source><creator>Jiao, Yonggang ; Li, Guocai ; Xing, Yilan ; Nie, Da'ao ; Liu, Xintong</creator><creatorcontrib>Jiao, Yonggang ; Li, Guocai ; Xing, Yilan ; Nie, Da'ao ; Liu, Xintong</creatorcontrib><description>•To study risk factors for hemorrhagic transformation (HT) in non-thrombolysis patients.•Hyperlipemia, atrial fibrillation, plateletcount, INR > 1.7 are correlated with HT.•Hyperlipemia is a protective factor for HT.•Atrial fibrillation, plateletcount, INR > 1.7 are the risk factors for HT.
Hemorrhagic transformation (HT) is a serious complication of acute cerebral infarction. The aim of study is to investigate the influencing factors of HT in non-thrombolysis patients with acute cerebral infarction, and to explore its clinical significance.
From June 2016 to March 2017, a total of 346 non-thrombolysis patients with acute cerebral infarction hospitalized in the Department of Neurology of Guangdong Second Provincial General Hospital, were chosen and randomly devided into the non-HT group (control) and HT group. A record of 17 indices including the patients’age, gender, hypertension, diabetes, dyslipidemia, hyperhomocystinemia, atrial fibrillation, drinking or smoking, anticoagulation, antithrombosis, international normalized ratio (INR) and platelet count were measured. Then regression analysis was made to find the independent factors for HT.
It was found that 38 of non-thrombolysis patients with acute cerebral infarction involved in this study were with HT. The indices including dyslipidemia, drinking, atrial fibrillation, antiplatelet aggregation, anticoagulation, INR > 1.7, cholesterin, triglyceride and platelet count showed statistical differences between the HT group and the non-HT group (P < 0.05). According to the binary logistic regression analysis, there was a negative correlation between dyslipidemia and HT (odds ratio (OR)=0.371, 95% confidence interval (CI) 0.186-0.740, P = 0.005), while there was a positive correlation between atrial fibrillation (OR=2.476, 95% CI 1.140–5.377, P=0.022), platelet count (OR=1.006, 95% CI 0.682–1.611, P = 0.007), INR>1.7 (OR=10.889, 95% CI 4.760–24.910, P = 0.000) and HT.
There is independent correlation between dyslipidemia, atrial fibrillation, platelet count, INR > 1.7 and HT. Dyslipidemia is the protective factor for HT, and atrial fibrillation, platelet count, INR > 1.7 are the risk factors for HT.</description><identifier>ISSN: 0303-8467</identifier><identifier>EISSN: 1872-6968</identifier><identifier>DOI: 10.1016/j.clineuro.2019.04.018</identifier><identifier>PMID: 31015060</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute cerebral infarction ; Age ; Anticoagulants ; Blood platelets ; Cardiac arrhythmia ; Cerebral infarction ; Consent ; Diabetes ; Diabetes mellitus ; Dyslipidemia ; Ethics ; Family medical history ; Fibrillation ; Hemorrhage ; Hemorrhagic transformation ; Hospitals ; Hypertension ; Ischemia ; Lipoproteins ; Neurology ; NMR ; Non-thrombolysis ; Nuclear magnetic resonance ; Patients ; Platelets ; Regression analysis ; Risk factors ; Smoking ; Stroke ; Thrombolysis</subject><ispartof>Clinical neurology and neurosurgery, 2019-06, Vol.181, p.68-72</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><rights>2019. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-c32b37fe08509e3ac495f042e734763d2a87324d24b6f07f7f8f44632c9c9b703</citedby><cites>FETCH-LOGICAL-c396t-c32b37fe08509e3ac495f042e734763d2a87324d24b6f07f7f8f44632c9c9b703</cites><orcidid>0000-0002-2662-903X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2218927015?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978,64366,64368,64370,72220</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31015060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiao, Yonggang</creatorcontrib><creatorcontrib>Li, Guocai</creatorcontrib><creatorcontrib>Xing, Yilan</creatorcontrib><creatorcontrib>Nie, Da'ao</creatorcontrib><creatorcontrib>Liu, Xintong</creatorcontrib><title>Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction</title><title>Clinical neurology and neurosurgery</title><addtitle>Clin Neurol Neurosurg</addtitle><description>•To study risk factors for hemorrhagic transformation (HT) in non-thrombolysis patients.•Hyperlipemia, atrial fibrillation, plateletcount, INR > 1.7 are correlated with HT.•Hyperlipemia is a protective factor for HT.•Atrial fibrillation, plateletcount, INR > 1.7 are the risk factors for HT.
Hemorrhagic transformation (HT) is a serious complication of acute cerebral infarction. The aim of study is to investigate the influencing factors of HT in non-thrombolysis patients with acute cerebral infarction, and to explore its clinical significance.
From June 2016 to March 2017, a total of 346 non-thrombolysis patients with acute cerebral infarction hospitalized in the Department of Neurology of Guangdong Second Provincial General Hospital, were chosen and randomly devided into the non-HT group (control) and HT group. A record of 17 indices including the patients’age, gender, hypertension, diabetes, dyslipidemia, hyperhomocystinemia, atrial fibrillation, drinking or smoking, anticoagulation, antithrombosis, international normalized ratio (INR) and platelet count were measured. Then regression analysis was made to find the independent factors for HT.
It was found that 38 of non-thrombolysis patients with acute cerebral infarction involved in this study were with HT. The indices including dyslipidemia, drinking, atrial fibrillation, antiplatelet aggregation, anticoagulation, INR > 1.7, cholesterin, triglyceride and platelet count showed statistical differences between the HT group and the non-HT group (P < 0.05). According to the binary logistic regression analysis, there was a negative correlation between dyslipidemia and HT (odds ratio (OR)=0.371, 95% confidence interval (CI) 0.186-0.740, P = 0.005), while there was a positive correlation between atrial fibrillation (OR=2.476, 95% CI 1.140–5.377, P=0.022), platelet count (OR=1.006, 95% CI 0.682–1.611, P = 0.007), INR>1.7 (OR=10.889, 95% CI 4.760–24.910, P = 0.000) and HT.
There is independent correlation between dyslipidemia, atrial fibrillation, platelet count, INR > 1.7 and HT. Dyslipidemia is the protective factor for HT, and atrial fibrillation, platelet count, INR > 1.7 are the risk factors for HT.</description><subject>Acute cerebral infarction</subject><subject>Age</subject><subject>Anticoagulants</subject><subject>Blood platelets</subject><subject>Cardiac arrhythmia</subject><subject>Cerebral infarction</subject><subject>Consent</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Dyslipidemia</subject><subject>Ethics</subject><subject>Family medical history</subject><subject>Fibrillation</subject><subject>Hemorrhage</subject><subject>Hemorrhagic transformation</subject><subject>Hospitals</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Lipoproteins</subject><subject>Neurology</subject><subject>NMR</subject><subject>Non-thrombolysis</subject><subject>Nuclear magnetic resonance</subject><subject>Patients</subject><subject>Platelets</subject><subject>Regression analysis</subject><subject>Risk factors</subject><subject>Smoking</subject><subject>Stroke</subject><subject>Thrombolysis</subject><issn>0303-8467</issn><issn>1872-6968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9v1DAQxS0EokvhK1SWuHBJmNiOHd9AFX8qVeICZ8txxrteJfZiJ6B-e7zalgMXLp6Df-_N6D1CbjpoO-jk-2Pr5hBxy6ll0OkWRAvd8IzsukGxRmo5PCc74MCbQUh1RV6VcgQAzuXwklzx6tGDhB3Z30U_bxhdiHvqrVtTLjR5esAl5Xyw--Domm0sPuXFriFFGiKNKTbrIadlTPNDCYWe6hfGtdDfYT1QhxnHbOeKepvdWfWavPB2LvjmcV6TH58_fb_92tx_-3J3-_G-cVzLtb5s5MojDD1o5NYJ3XsQDBUXSvKJ2UFxJiYmRulBeeUHL4TkzGmnRwX8mry7-J5y-rlhWc0SisN5thHTVgxjHddM9Kyv6Nt_0GPacqzXnalBM1VDqpS8UC6nUjJ6c8phsfnBdGDOVZijearCnKswIEytogpvHu23ccHpr-wp-wp8uABY8_gVMJviaogOp5DRrWZK4X87_gDuKp77</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Jiao, Yonggang</creator><creator>Li, Guocai</creator><creator>Xing, Yilan</creator><creator>Nie, Da'ao</creator><creator>Liu, Xintong</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2662-903X</orcidid></search><sort><creationdate>201906</creationdate><title>Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction</title><author>Jiao, Yonggang ; Li, Guocai ; Xing, Yilan ; Nie, Da'ao ; Liu, Xintong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-c32b37fe08509e3ac495f042e734763d2a87324d24b6f07f7f8f44632c9c9b703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute cerebral infarction</topic><topic>Age</topic><topic>Anticoagulants</topic><topic>Blood platelets</topic><topic>Cardiac arrhythmia</topic><topic>Cerebral infarction</topic><topic>Consent</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Dyslipidemia</topic><topic>Ethics</topic><topic>Family medical history</topic><topic>Fibrillation</topic><topic>Hemorrhage</topic><topic>Hemorrhagic transformation</topic><topic>Hospitals</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Lipoproteins</topic><topic>Neurology</topic><topic>NMR</topic><topic>Non-thrombolysis</topic><topic>Nuclear magnetic resonance</topic><topic>Patients</topic><topic>Platelets</topic><topic>Regression analysis</topic><topic>Risk factors</topic><topic>Smoking</topic><topic>Stroke</topic><topic>Thrombolysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiao, Yonggang</creatorcontrib><creatorcontrib>Li, Guocai</creatorcontrib><creatorcontrib>Xing, Yilan</creatorcontrib><creatorcontrib>Nie, Da'ao</creatorcontrib><creatorcontrib>Liu, Xintong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neurology and neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiao, Yonggang</au><au>Li, Guocai</au><au>Xing, Yilan</au><au>Nie, Da'ao</au><au>Liu, Xintong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction</atitle><jtitle>Clinical neurology and neurosurgery</jtitle><addtitle>Clin Neurol Neurosurg</addtitle><date>2019-06</date><risdate>2019</risdate><volume>181</volume><spage>68</spage><epage>72</epage><pages>68-72</pages><issn>0303-8467</issn><eissn>1872-6968</eissn><abstract>•To study risk factors for hemorrhagic transformation (HT) in non-thrombolysis patients.•Hyperlipemia, atrial fibrillation, plateletcount, INR > 1.7 are correlated with HT.•Hyperlipemia is a protective factor for HT.•Atrial fibrillation, plateletcount, INR > 1.7 are the risk factors for HT.
Hemorrhagic transformation (HT) is a serious complication of acute cerebral infarction. The aim of study is to investigate the influencing factors of HT in non-thrombolysis patients with acute cerebral infarction, and to explore its clinical significance.
From June 2016 to March 2017, a total of 346 non-thrombolysis patients with acute cerebral infarction hospitalized in the Department of Neurology of Guangdong Second Provincial General Hospital, were chosen and randomly devided into the non-HT group (control) and HT group. A record of 17 indices including the patients’age, gender, hypertension, diabetes, dyslipidemia, hyperhomocystinemia, atrial fibrillation, drinking or smoking, anticoagulation, antithrombosis, international normalized ratio (INR) and platelet count were measured. Then regression analysis was made to find the independent factors for HT.
It was found that 38 of non-thrombolysis patients with acute cerebral infarction involved in this study were with HT. The indices including dyslipidemia, drinking, atrial fibrillation, antiplatelet aggregation, anticoagulation, INR > 1.7, cholesterin, triglyceride and platelet count showed statistical differences between the HT group and the non-HT group (P < 0.05). According to the binary logistic regression analysis, there was a negative correlation between dyslipidemia and HT (odds ratio (OR)=0.371, 95% confidence interval (CI) 0.186-0.740, P = 0.005), while there was a positive correlation between atrial fibrillation (OR=2.476, 95% CI 1.140–5.377, P=0.022), platelet count (OR=1.006, 95% CI 0.682–1.611, P = 0.007), INR>1.7 (OR=10.889, 95% CI 4.760–24.910, P = 0.000) and HT.
There is independent correlation between dyslipidemia, atrial fibrillation, platelet count, INR > 1.7 and HT. Dyslipidemia is the protective factor for HT, and atrial fibrillation, platelet count, INR > 1.7 are the risk factors for HT.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31015060</pmid><doi>10.1016/j.clineuro.2019.04.018</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-2662-903X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0303-8467 |
| ispartof | Clinical neurology and neurosurgery, 2019-06, Vol.181, p.68-72 |
| issn | 0303-8467 1872-6968 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2213924525 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; ProQuest Central UK/Ireland |
| subjects | Acute cerebral infarction Age Anticoagulants Blood platelets Cardiac arrhythmia Cerebral infarction Consent Diabetes Diabetes mellitus Dyslipidemia Ethics Family medical history Fibrillation Hemorrhage Hemorrhagic transformation Hospitals Hypertension Ischemia Lipoproteins Neurology NMR Non-thrombolysis Nuclear magnetic resonance Patients Platelets Regression analysis Risk factors Smoking Stroke Thrombolysis |
| title | Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A17%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influencing%20factors%20of%20hemorrhagic%20transformation%20in%20non-thrombolysis%20patients%20with%20cerebral%20infarction&rft.jtitle=Clinical%20neurology%20and%20neurosurgery&rft.au=Jiao,%20Yonggang&rft.date=2019-06&rft.volume=181&rft.spage=68&rft.epage=72&rft.pages=68-72&rft.issn=0303-8467&rft.eissn=1872-6968&rft_id=info:doi/10.1016/j.clineuro.2019.04.018&rft_dat=%3Cproquest_cross%3E2213924525%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2218927015&rft_id=info:pmid/31015060&rft_els_id=S0303846719301210&rfr_iscdi=true |